The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine―oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pa... by GOLDSTEIN, D, SPRY, N, SHAPIRO, J, PORTER, I. W. T, HRUBY, G, HORVATH, L, BYDDER, S, UNDERHILL, C, HARVEY, J, GEBSKI, V. J, CUMMINS, M. M, BROWNS, C, HAZEL, G. A.Van, CARROLL, S, SELVA-NAYAGAM, S, BORG, M, ACKLAND, S. P, WRATTEN, C

Get full text